Abstract
Introduction. Prodromic symptoms can offer a therapeutic opportunity to the patients with migraine. Objectives: to determine clinical characteristics of prodromic symptoms and to compare the differences between migraine with and without aura and chronic migraine in an Colombian university population.
Materials and Methods. We make a cross sectional study by means of a semi-structured, validated in Spanish interview designed to identify primary headaches among university students. The students answered a diagnostic questionnaire of migraine; who were detected with migraine then were interviewed face to face bya a neurologist by a semi structured interview.
Results. 141 patients were interviewed with migraine. 29.8% patients with migraine had prodromic symptoms with varied characteristic and a median duration of 30 minutes. The time of maximum intensity of migraine is also variable with a median of 13.5 minutes. 24.1% of the patients refer a maximum intensity of the headache from the beginning. There were not differences in the frequency and duration of prodromic symptoms, or time of maximum intensity of the pain among patients with migraine with aura, migraine without aura or chronic migraine.
Conclusions. The medication used to prevent a migraine attack during the prodromic phase are only usable in the third part of the patients with migraine and they shoud act before 30 minutes. These finds limit the clinical utility of the prodromic symptoms and the therapeutic options to use during the prodrome of the migraine attack.
References
Zagami AS, Rasmussen BK. Symptomatology of migraine without aura. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches, second edition. Philadelphia: Lippincott Williams & Wilkins, 2000; p. 337-343.
Mathew NT, Kailasam J, Meadors L. Early treatment of Migraine with rizatriptan: A Placebo controlled Study. Headache 2004; 44: 669-673.
Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000; 40: 792-797.
Pascual J, Cabarrocas X. Within patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache 2002; 42: 28-31.
Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984; 4: 85-90.
Luciani R, Carter D, Mannix L, Hemphill M, Diamond M, Cady R. Prevention of migraine during prodrome with naratriptan. Cephalalgia 2000; 20: 122-126.
Rueda-Sánchez M, Díaz-Martínez LA. Validation of a migraine screening questionnaire in a Colombian university population. Cephalalgia 2004; 24: 894-899.
Rueda-Sánchez M. Características clínicas de la migraña en la población general colombiana. Acta Neurol Colomb 2009; 25: 63-74.
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 2004; 24(Suppl. 1): 1-160.
Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996; 16: 239- 245.
Kallela M, Wessman M, Färkkilä M, Palitie A, Koskenvuo M, Honkaslao M-L, Kaprio J. Clinical characteristics of migraine in a population-based twin sample: similarities and differences between migraine with and without aura. Cephalalgia 1999; 19: 151-158.
Kelman, L. The premonitoy symptoms (Prodome): A tertiary care study of 893 migraineurs. Headache 2004; 44: 865-872.
Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221-228.
Waelkens J. Warning symptoms in migraine: characteristics and therapeutic implications. Cephalalgia 1985; 5: 223-228.
Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15: 45-68.
Evans RW, Mannix LK. Triptans for migraine prodrome. Headache 2002; 42: 83-84.
Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al. Premonitory symptoms in migraine. An electronic diary study. Neurology 2003; 60: 935-940.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.